Sepsis in patients with haematological versus solid cancer: a retrospective cohort study
Open Access
Abstract
Objectives This study aims to examine the outcome of haematological and patients with solid cancer presenting with sepsis to the emergency department (ED). Design Single-centred, retrospective cohort study. Setting conducted at an academic emergency department of a tertiary hospital. Participants All patients >18 years of age admitted with sepsis were included. Interventions Patients were stratified into two groups: haematological and solid malignancy. Primary and secondary outcome The primary outcome of the study was in-hospital mortality. Secondary outcomes included intensive care unit (ICU) mortality, ICU and hospital lengths of stay and mechanical ventilation duration. Results 442 sepsis cancer patients were included in the study, of which 305 patients (69%) had solid tumours and 137 patients (31%) had a haematological malignancy. The mean age at presentation was 67.92 (±13.32) and 55.37 (±20.85) (pConclusion Solid tumour patients with sepsis or septic shock are at the same risk of mortality as patients with haematological tumours. However, haematological malignancy patients admitted with sepsis or septic shock have higher rates of bacteraemia.Keywords
This publication has 25 references indexed in Scilit:
- Trial of Early, Goal-Directed Resuscitation for Septic ShockNew England Journal of Medicine, 2015
- Goal-Directed Resuscitation for Patients with Early Septic ShockNew England Journal of Medicine, 2014
- Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?Therapeutics and Clinical Risk Management, 2014
- A Randomized Trial of Protocol-Based Care for Early Septic ShockNew England Journal of Medicine, 2014
- Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center studyIntensive Care Medicine, 2012
- Lung Cancer in Chronic Obstructive Pulmonary Disease: Enhancing Surgical Options and OutcomesAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- Intensive care of the cancer patient: recent achievements and remaining challengesAnnals of Intensive Care, 2011
- Cancer patients with septic shock: mortality predictors and neutropeniaSupportive Care in Cancer, 2004
- Polymicrobial Septicemia in the Cancer PatientMedicine, 1986